Jeff Kim is the co-founder and CEO of Slingshot Biosciences, a biotech that designs and manufactures synthetic cells for R&D, clinical diagnostics, and engineered cell therapies. Slingshot Biosciences' mission is to overcome supply chain and cost barriers that restrict access to advanced diagnostics and therapeutics.
Jeff is a serial entrepreneur, having co-founded and run multiple successful companies, including Radiant Genomics, which was eventually acquired by Zymergen, and Pattern Ag, a company mapping soil microbes to help farmers grow their bottom line. Before Radiant, Jeff was a scientist at the Lawrence Berkeley National Lab, and was the project lead for jet fuel development at Amyris Biotechnologies.
